Trial of An Innovative Smartphone Intervention for Smoking Cessation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02724462|
Recruitment Status : Completed
First Posted : March 31, 2016
Results First Posted : January 5, 2021
Last Update Posted : January 5, 2021
- Study Details
- Tabular View
- Study Results
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Smoking||Behavioral: Smartphone-delivered Intervention (SmartQuit) Behavioral: : Smartphone-delivered Intervention (Standard of care app)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||2503 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Randomized Trial of An Innovative Smartphone Intervention for Smoking Cessation|
|Actual Study Start Date :||May 27, 2017|
|Actual Primary Completion Date :||December 27, 2019|
|Actual Study Completion Date :||December 27, 2019|
This is the experimental arm of the study. This includes receiving the novel/experimental smartphone smoking cessation app. Therapy description withheld to protect the integrity of the study.
Behavioral: Smartphone-delivered Intervention (SmartQuit)
The experimental arm includes an intervention using a novel smartphone smoking cessation app.
Active Comparator: Control
This is the control arm of the study. This includes receiving the standard of care smartphone smoking cessation app. Therapy description withheld to protect the integrity of the study.
Behavioral: : Smartphone-delivered Intervention (Standard of care app)
The control intervention uses a standard of care smartphone smoking cessation app.
- 30-day Point Prevalence Abstinence, Complete-case [ Time Frame: 12 months post randomization ]Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are excluded for the complete-case analysis. Exact 2-sided CI was based on the observed proportion of participants.
- 30-day Point Prevalence Abstinence, Missing=Smoking Imputation [ Time Frame: 12 months post randomization ]Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are imputed as still smoking. Exact 2-sided CI was based on the observed proportion of participants.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- age 18 or older
- smokes at least five cigarettes daily for at least past 12 months
- wants to quit cigarette smoking in the next 30 days
- if concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days
- interested in learning skills to quit smoking
- willing to be randomly assigned to either condition
- resides in US
- has at least daily access to their own personal Apple iPhone, Android, or Windows Phone
- knows how to login and download a smartphone application
- willing and able to read in English
- not using other smoking cessation interventions (including apps or our other intervention studies).
- willing to complete all three follow-up surveys
- provide email, phone, and mailing address.
- The exclusion criteria are opposite of the inclusion criteria listed above.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02724462
|United States, Washington|
|Fred Hutchinson Cancer Research Center|
|Seattle, Washington, United States, 98109|
|Principal Investigator:||Jonathan Bricker, Ph.D.||Fred Hutchinson Cancer Center|
Documents provided by Fred Hutchinson Cancer Center:
|Responsible Party:||Fred Hutchinson Cancer Center|
|Other Study ID Numbers:||
NCI-2018-02662 ( Registry Identifier: NCI / CTRP )
RG1001191 ( Other Identifier: Fred Hutch/University of Washington Cancer Consortium )
R01CA192849 ( U.S. NIH Grant/Contract )
|First Posted:||March 31, 2016 Key Record Dates|
|Results First Posted:||January 5, 2021|
|Last Update Posted:||January 5, 2021|
|Last Verified:||November 2020|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
app for quitting smoking